✦ LIBER ✦

360 The Association of Chemotherapy-induced Thrombocytopaenia with CYP2C19 and ALDH2 Genetic Polymorphisms in Chinese Breast Cancer Patients

✍ Scribed by W. Yeo; V.T.C. Chan; R. Ng; E. Pang; F.K.F. Mo; J.J.S. Suen; C.D. Liao; X.Y. Wang; W.M. Ho; N.L.S. Tang

Book ID: 117662268
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70426-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association between Genetic Polymorphism

Association between Genetic Polymorphisms of CYP2D6 and Outcomes in Breast Cancer Patients with Tamoxifen Treatment

✍ Park, Hyung Seok; Choi, Ji-Yeob; Lee, Mi-Jeong; Park, Seho; Yeo, Chang-Woo; Lee, 📂 Article 📅 2011 🏛 Korean Academy of Medical Sciences 🌐 English ⚖ 573 KB

Lack of association between genetic poly

Lack of association between genetic polymorphisms of CYP3A4 , CYP2C9 and CYP2C19 and antituberculosis drug-induced liver injury in a community-based Chinese population

✍ Tang, Shao-Wen; Lv, Xiao-Zhen; Chen, Ru; Wu, Shan-Shan; Yang, Zhi-Rong; Chen, Da 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Genetic polymorphisms of CYP2D6*10 and C

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

✍ Matthew Goetz; Vera Suman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

The study by Okishiro et al 1 concludes that the cytochrome P450 (CYP) genotype CYP2D6\*10/\*10 is unlikely to have a clinically significant impact on prognosis in women with breast cancer who receive adjuvant tamoxifen. However, several aspects of the study by Okishiro et al call their conclusions

Genetic polymorphisms of CYP2D6*10 and C

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

✍ Masatsugu Okishiro; Tetsuya Taguchi; Seung Jin Kim; Kenzo Shimazu; Yasuhiro Tama 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

0150 The severity of chemotherapy-induce

0150 The severity of chemotherapy-induced neutropenia in association with PTGS-2 gene polymorphism in breast cancer patients

✍ W. Yeo; J.J.S. Suen; W.M. Ho; F.K.F. Mo; S.L. Chan; K.C. Lam; A.N.Y. Poon; N.L.S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Reply to Genetic polymorphisms of CYP2D6

Reply to Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

✍ Shinzaburo Noguchi; Masatsugu Okishiro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 1 views